Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viatris Inc (NQ: VTRS )

10.92 -0.25 (-2.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,101,679
Open 11.14
Bid (Size) 10.92 (1)
Ask (Size) 11.07 (6)
Prev. Close 11.17
Today's Range 10.85 - 11.14
52wk Range 8.420 - 15.60
Shares Outstanding 1,212,301,241
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Better Dividend Stock: AbbVie or Viatris?
These pharmaceutical companies are profitable and offer above-average dividends. 
Via The Motley Fool
What Does Viatris' Debt Look Like?
Over the past three months, shares of Viatris' Inc. (NASDAQ:VTRS) moved higher by 8.16%. Before having a look at the importance of debt, let's look at how much debt Viatris' has. 
Via Benzinga

Performance

YTD
-23.15%
-23.15%
1 Month
-0.46%
-0.46%
3 Month
+16.05%
+16.05%
6 Month
-7.22%
-7.22%
1 Year
-12.22%
-12.22%

More News

Read More
3 Stocks With Dividends of 3% or More to Buy on the Dip
Via The Motley Fool
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
From Oyster Point Pharma, Inc.
Via Globe NewsWire
Expert Ratings for Viatris
Via Benzinga
Where Viatris Stands With Analysts
Via Benzinga
4 Analysts Have This to Say About Viatris
Via Benzinga
Why Viatris Stock Is Jumping Today
Via The Motley Fool
Analyst Ratings for Viatris
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Via Benzinga
Want to Collect a High Dividend Every Month? Buy These 3 Stocks
Via The Motley Fool
Ocuphire Pharma Shares Jump After Global Licensing Pact For Nyxol Eye Drops
Via Benzinga
Why Viatris Shares Are Soaring Higher
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)
From Brodsky & Smith LLC
Via Globe NewsWire
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
Via Benzinga
Oyster Point Pharma (NASDAQ: OYST) Enters Into Agreement to be Acquired by Viatris (NASDAQ: VTRS) For $11 Per Share Plus CVR Up to $2.00 Per Share
Via Spotlight Growth
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Via Benzinga
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
Via Benzinga
IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal
Via InvestorPlace
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Viatris (VTRS) Stock Pops 17% on Acquisition News
Via InvestorPlace
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
Via Benzinga
Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'
Via Benzinga
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
From Oyster Point Pharma, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.